Remdesivir and tixagevimab plus cilgavimab for treating COVID-19

Supporting evidence

• Evaluation report

• Draft guidance consultation 1 committee papers (PDF 15.33 MB)

  Published:

  08 May 2024

• Draft guidance consultation 2 committee papers (PDF 4.38 MB)

  Published:

  08 May 2024

• Final draft guidance 1 committee papers (PDF 10.21 MB)

  Published:

  08 May 2024

• Final draft guidance 2 committee papers (PDF 2.48 MB)

  Published:

  08 May 2024